Craft

Accellacare UK

Revenue

£9.4 M

FY, 2021

Accellacare UK Summary

Company Summary

Overview
Accellacare UK (formerly known as MeDiNova Research) is a clinical research company that provides clinical trial services. It specializes in pneumococcal vaccines, chronic obstructive pulmonary disease, respiratory syncytial virus, osteoarthritis, psoriasis, and post-surgical neuropathic pain clinical trials.
Type
Subsidiary
Status
Active
Founded
1997
HQ
Coventry, GB | view all locations
Website
https://www.accellacare.com
Cybersecurity rating
Sectors

Key People

  • Michala Worrell

    Michala Worrell, Vice President, EMEA Operations

  • Paul Ivan
  • Rachael Buck

    Rachael Buck, Director, Project Management EMEA

Operating MetricsView all

Countries

55

Apr, 2023

Patients

8.1M

Apr, 2023

LocationsView all

1 location detected

  • Coventry, England HQ

    United Kingdom

    Friars House, Manor House Dr

Accellacare UK Financials

Summary Financials

Revenue (FY, 2021)
£9.4M
Gross profit (FY, 2021)
£7.8M
Net income (FY, 2021)
£742.9K
Cash (FY, 2021)
£822.8K
EBIT (FY, 2021)
£980.5K

Footer menu